drugset / Trial / NCT05354713

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

NCT05354713 ↗

Phase 1 Completed 58 enrolled NVP Healthcare
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2

Timeline

Start
2022-11-05
Primary completion
2023-03-20
Completion
2023-04-27

Drugs

EvaluationDrugModalityDoseRoute
Subject NVP-1805 Unknown — Oral
Comparator NVP-1805-R1 Unknown 80 mg Oral
Comparator NVP-1805-R2 Unknown — Oral

Indications

No indication recorded.